ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HYPD vs SER // FORWARD P/E MULTIPLE

Hyperion DeFi Inc. (NASDAQ) VS. Serina Therapeutics Inc. (NYSE) • 15-METRIC TALLY: HYPD 3 — SER 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HYPD VS. SER) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HYPD SER SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% 132.10% +47.90 HYPD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 3/9 +2.00 HYPD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.4 52.3 -2.90 SER /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $49.7M $49.3M $447.9K HYPD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HYPD REV SER REV HYPD GROSS % SER GROSS % HYPD FCF SER FCF
FY 2025 $813.5K $130.0K 62.7% — -$14.8M -$18.0M
FY 2024 $57.3K $56.0K -50.0% — -$30.3M -$17.2M
FY 2023 $3.8K $3.2M — — -$23.8M -$2.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HYPD // BETA —
SER // BETA —